BRAVECTO® (fluralaner) Chews for Dogs
Canine Parasiticides
Product Description
BRAVECTO® (Fluralaner) Chews for Dogs kills fleas, treats and prevents flea infestations, and kills ticks (black-legged tick, American dog tick, brown dog tick and Asian longhorned tick) for 12 weeks. BRAVECTO also kills lone star ticks for 8 weeks. BRAVECTO is for dogs and puppies 6 months of age and older and weighing 4.4lbs and greater. BRAVECTO must be prescribed by your veterinarian. BRAVECTO is available in 5 strengths based on your dog’s weight.
| Product Name | Pkg Size | GTIN#/UPC# | UIN# |
|---|---|---|---|
| BRAVECTO® Toy Dogs (FLURALANER) > 4.4 – 9.9 lbs | 10 x 1 x 112.5mg | 662858399806 | 139552 |
| BRAVECTO® Small Dogs (FLURALANER) > 9.9 – 22 lbs | 10 x 1 x 250mg | 662858267211 | 143323 |
| BRAVECTO® Medium Dogs (FLURALANER) > 22 – 44 lbs | 10 x 1 x 500mg | 662858313512 | 128951 |
| BRAVECTO® Large Dogs (FLURALANER) > 44 – 88 lbs | 10 x 1 x 1000mg | 662858247930 | 144000 |
| BRAVECTO® Extra Large Dogs (FLURALANER) >88 -123 lbs | 10 x 1 x 1400mg | 662858363876 | 147371 |
Images
*BRAVECTO kills fleas and prevents flea infestation. Bravecto Chew and Bravecto Topical for Dogs kills ticks (black-legged tick, American dog tick, brown dog tick and Asian longhorned tick) for 12 weeks and also kills lone star ticks for 8 weeks. Bravecto Topical for Cats kills ticks (black-legged tick) for 12 weeks and American dog ticks for 8 weeks.
Important Safety Information
BRAVECTO (fluralaner) Chews for Dogs: The most commonly reported adverse reactions include vomiting, lethargy, diarrhea, anorexia and pruritus. In some cases, adverse events have been reported following use in breeding females. BRAVECTO Chews has not been shown to be effective for 12-weeks’ duration in puppies less than 6 months of age. BRAVECTO Chews is not effective against lone star ticks beyond 8 weeks of dosing. Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders.
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global